High expression of FMNL1 is significantly correlated with advanced tumor stage, higher pathological tumor grade, tumor metastasis, and unfavorable prognosis in two independent cohorts containing over 800 patients with ccRCC. This evidence concerns the gene FMNL1 and nonpapillary renal cell carcinoma.